Applications of the genO‑hCD3ε/hCD28 mouse model

Useful applications for researchers working on different biomedical fields, such as immuno-oncology and autoimmunity:

  • Assess the efficacy of CD28 and/or CD3ε (SP-34)-targeting therapeutics such as:
    • Immune checkpoint inhibitors
    • T-cell engagers targeting the CD3 SP34 epitope
  • Perform tumor growth inhibition assays in the context of monotherapies or combotherapies
  • Investigate the mode of action (MoA) of various compounds and understand their therapeutic potential

 Features

  • Physiological regulation and expression pattern of CD3ε and human CD28
  • Conserved interaction with CD3γ, CD3δ and CD3ζ subunits
  • Fully functional mouse immune system
  • Lack of expression of the murine target genes

Clients

No items found.

Model Delivery & Logistics

  • Breeding facilities in the US and Europe through our trusted partners:
  • Quick, compliant, and reliable door-to-door delivery worldwide
  • Models with certified SOPF health status from AAALAC-accredited and PHS-assured professional breeders in the US and Europe

Validation data

Discover related products to

genO-hCD3ε/hCD28

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CD3
CD28
T-cell engager
Immune checkpoint

genO-panhCD3/hCD28

Double-humanized genO-panhCD3/hCD28 immunocompetent mice enable the efficacy assessment of anti-CD3 and CD28 compounds.

Immune checkpoint
CD28
ICP (single-target)
T-cell engager

genO‑hCD28

The genO‑hCD28 mouse enables the in vivo efficacy assessment and profiling of immuno-oncology agents targeting the human immune checkpoint CD28 in fully immunocompetent mice.

T-cell engager
CD3

genO‑hCD3ε

genO‑hCD3ε immunocompetent mice enable the preclinical in vivo efficacy assessment of T-cell engagers, to study cancer cell recognition, immunosuppressant therapies, etc.

T-cell engager
CD3

genO‑panhCD3

genO‑panhCD3 immunocompetent mice enable the efficacy assessment of T-cell engagers, to study cancer cell recognition, immunosuppressant therapies, etc.

Preclinical double-humanized genO‑hCD3ε/hCD28 mouse model

Get in touch about

Let us know how we can help

Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe